
Tesla Looks to End 3-Day Skid, Pharma Stock Plunges 50% After Pfizer Ends Partnership
The Rundown
00:00
Market Volatility and Year-End Reflections
This chapter analyzes recent stock market changes, highlighting Tesla's modest gains and Sangamo Therapeutics' significant decline after Pfizer's partnership withdrawal. The discussion also touches on the rise in ETF investments and concludes with a note of appreciation for the audience's support and a glimpse of future content.
Transcript
Play full episode